Liabilities Breakdown
4.9 M
Current Liabilities
19.1 M
Long-Term Liabilities
| Deposit Liabilities | 4,473.68 | |
| Total Liabilities | 23.96 Million | |
| Current Liabilities | 4.89 Million | |
| Long-Term Liabilities | 19.06 Million |
Will Cel Sci (NYSEMKT:CVM) investors stop to drop in January?
 | By Rifka Kats | Macroaxis Story |
Cel Sci is scheduled to announce its earnings tomorrow. Cel Sci Price to Book Value is relatively stable at the moment as compared to the past year. The company's current Price to Book Value is estimated at 71.54. Price to Sales Ratio is expected to hike to 505.12 this year, although the value of Earnings Before Interest Taxes and Depreciation Amortization EBITDA will most likely fall to (19.1 M). As many of us are excited about healthcare space, it is fair to summarize Cel Sci as a unique alternative. We will summarize if it could be a much better year for Cel Sci shareholders.
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Michael Smolkin
This firm has 14.16 M in debt with debt to equity (D/E) ratio of 0.74, which is OK given its current industry classification. The company has a current ratio of 4.78, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. CEL SCI financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures the total debt position of CEL SCI, including all of CEL SCI's outstanding debt obligations, and compares it with the equity. In simple terms, the high financial leverage means the cost of production, together with running the business day-to-day, is high, whereas, lower financial leverage implies lower fixed cost investment in the business and generally considered by investors to be a good sign. So if creditors own a majority of CEL SCI assets, the company is considered highly leveraged. Understanding the composition and structure of overall CEL SCI debt and outstanding corporate bonds gives a good idea of how risky the capital structure of a business is and if it is worth investing in it. Please read more on our technical analysis page.
Watch out for price decline
Please consider monitoring CEL SCI on a daily basis if you are holding a position in it. CEL SCI is trading at a penny-stock level, and the possibility of delisting is much higher compared to other stocks. However, just because the stock is trading under one dollar, does not mean it will be marked for deletion. Most exchanges require public instruments, such as CEL SCI stock to be traded above the $1 level to remain listed. If CEL SCI stock price falls below $1 for 30 consecutive trading days, the exchange can delist it. Once the company reaches this point, they will be sent an initial price violation notice directly from an exchange.
Understanding CEL Total Liabilities
CEL SCI Corp liabilities are broken down into two parts on the balance sheet. These are short-term (or current) obligations and long-term debt. CEL SCI Corp has to fulfill its short-term liabilities in this reporting year and should be no more than 12 months old. Long-term debt, on the other hand, is anything beyond the 12-month payment timeframe. Common short-term liabilities found on CEL SCI balance sheet include debt obligations and money owed to different CEL SCI vendors, workers, and loan providers. Below is the chart of CEL short long-term liabilities accounts currently reported on its balance sheet. You can use CEL SCI Corp financial leverage analysis tool to get a better grip on understanding its financial positionHow important is CEL SCI's Liquidity
CEL SCI financial leverage refers to using borrowed capital as a funding source to finance CEL SCI Corp ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. CEL SCI financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to CEL SCI's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of CEL SCI's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between CEL SCI's total debt and its cash.
Another angle On CEL SCI
Cel Sci reported the last year's revenue of 606.74 K. Reported Net Loss for the year was (29.58 M) with loss before taxes, overhead, and interest of (12.2 M).
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Rifka Kats do not own shares of CEL SCI Corp. Please refer to our Terms of Use for any information regarding our disclosure principles.